Literature DB >> 29521675

Splenectomy in Gaucher Disease: A Call for Minimally Invasive Surgery.

Michael R Freund1, Petachia Reissman1, Ari Zimran2, Joseph Alberton1.   

Abstract

OBJECTIVE: The objective of this article was to demonstrate that Gaucher disease (GD) patients with refractory hypersplenism and massive splenomegaly may successfully undergo hand-assisted laparoscopic splenectomy (HALS).
METHODS: This was a retrospective audit conducted at the Gaucher clinic at a national referral center over a 10-year period. PATIENT POPULATION: This study included 8 GD patients who underwent hand-assisted or conventional laparoscopic splenectomy for massive or complicated splenomegaly between the years 2007 and 2017.
RESULTS: Seven patients underwent an elective HALS procedure because of refractory hypersplenism, whereas 1 patient underwent an urgent conventional laparoscopic splenectomy because of torsion of a wandering spleen. Only 1 patient required conversion to open surgery because of multiple adhesions from a previous partial splenectomy. The mean weight of the removed spleens was 2373 g (range, 480 to 4900 g), mean craniocaudal length of the removed spleens was 25 cm (range, 20 to 33.5 cm), and mean operating time was 150 minutes (range, 96 to 280 min). Postoperative complications were limited to 2 patients and included thrombosis of the splenic vein stump in 1 patient, and propagation of a preoperative splenic vein thrombus to the portal system, as well as an accumulation of an intra-abdominal hematoma in another patient. There was no mortality. Mean length of hospital stay was 5 days (range, 2 to 11 d).
CONCLUSION: HALS for GD patients with refractory hypersplenism and massive splenomegaly is safe and feasible in experienced hands.

Entities:  

Mesh:

Year:  2018        PMID: 29521675     DOI: 10.1097/SLE.0000000000000518

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

Review 1.  A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact.

Authors:  Ari Zimran; Rosa Ruchlemer; Shoshana Revel-Vilk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide.

Authors:  Atul Mehta; Uma Ramaswami; Joseph Muenzer; Roberto Giugliani; Kurt Ullrich; Tanya Collin-Histed; Zoya Panahloo; Hartmann Wellhoefer; Joel Frader
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.